Guided Therapeutics (GTHP) EBITDA (2010 - 2025)
Guided Therapeutics' (GTHP) quarterly EBITDA came in at -$710000.0 in Q4 2025, down 32.96% year-on-year from -$1.1 million in Q4 2024, and down 46.39% quarter-over-quarter from -$485000.0 in Q3 2025.
Guided Therapeutics (GTHP) EBITDA (2010 - 2025) Analysis & Trends
Guided Therapeutics has disclosed EBITDA across 16 years of filings, most recently posting -$710000.0 for Q4 2025.
- EBITDA for Q4 2025 came in at -$710000.0, down 32.96% year-over-year; the trailing twelve-month figure through Dec 2025 was -$2.4 million (down 12.47% YoY), and the FY2025 annual result was -$2.4 million, down 12.52% from the prior year.
- EBITDA came in at -$710000.0 for Q4 2025 at Guided Therapeutics, down from -$485000.0 in the prior quarter.
- In the past five years, EBITDA ranged from a high of -$359000.0 in Q1 2024 to a low of -$1.5 million in Q2 2023.
- The 5-year median for EBITDA is -$592000.0 (2021), against an average of -$678750.0.
- Across the five-year window, EBITDA tumbled 240.08% in 2021 and jumped 57.41% in 2024, its largest moves.
- Guided Therapeutics' EBITDA stood at -$435000.0 in 2021, then plunged by 117.93% to -$948000.0 in 2022, then soared by 48.84% to -$485000.0 in 2023, then declined by 10.1% to -$534000.0 in 2024, then sank by 32.96% to -$710000.0 in 2025.
- The last three EBITDA figures came in at -$710000.0 (Q4 2025), -$485000.0 (Q3 2025), and -$763000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 1.35 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 936.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 1.46 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 1.10 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 477.60 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 663.81 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 255.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 515.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 316.80 Mn |
| 10 | Guided Therapeutics | - | - | 458,000.00 | -710,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -710,000.00 |
| Sep 30, 2025 | -485,000.00 |
| Jun 30, 2025 | -763,000.00 |
| Mar 31, 2025 | -414,000.00 |
| Dec 31, 2024 | -534,000.00 |
| Sep 30, 2024 | -561,000.00 |
| Jun 30, 2024 | -655,000.00 |
| Mar 31, 2024 | -359,000.00 |
| Dec 31, 2023 | -485,000.00 |
| Sep 30, 2023 | -623,000.00 |
| Jun 30, 2023 | -1.51 Mn |
| Mar 31, 2023 | -843,000.00 |
| Dec 31, 2022 | -948,000.00 |
| Sep 30, 2022 | -1.22 Mn |
| Jun 30, 2022 | -717,000.00 |
| Mar 31, 2022 | -443,000.00 |
| Dec 31, 2021 | -435,000.00 |
| Sep 30, 2021 | -487,000.00 |
| Jun 30, 2021 | -561,000.00 |
| Mar 31, 2021 | -823,000.00 |